KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa05200
|
Pathways in cancer |
CTBP1,CDK6,BCL2,MITF,PTGS2,CDC42, |
2.04E-5 |
hsa04370
|
VEGF signaling pathway |
PTGS2,PXN,CDC42, |
4.29E-2 |
hsa05222
|
Small cell lung cancer |
CDK6,BCL2,PTGS2, |
5.36E-2 |
hsa04510
|
Focal adhesion |
BCL2,PXN,CDC42, |
2.86E-1 |
hsa05218
|
Melanoma |
CDK6,MITF, |
9.37E-1 |
|
hsa05212
|
Pancreatic cancer |
CDK6,CDC42, |
9.50E-1 |
hsa05220
|
Chronic myeloid leukemia |
CTBP1,CDK6, |
9.88E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0042127
|
regulation of cell proliferation |
CTBP1,CDK6,CXADR,BCL2,MITF,PTGS2,ESRRA, |
3.85E-4 |
GO:0010629
|
negative regulation of gene expression |
NCOA2,CTBP1,E2F6,KDM1A,BNIP3L,KDM5B, |
4.02E-4 |
GO:0045892
|
negative regulation of transcription, DNA-dependent |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
1.07E-2 |
GO:0006355
|
regulation of transcription, DNA-dependent |
EZH2,NCOA2,CTBP1,MITF,E2F6,KDM1A,ESRRA,KDM5B,YBX1, |
1.10E-2 |
GO:0008285
|
negative regulation of cell proliferation |
CTBP1,CDK6,CXADR,BCL2,PTGS2, |
1.13E-2 |
|
GO:0051253
|
negative regulation of RNA metabolic process |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
1.14E-2 |
GO:0051252
|
regulation of RNA metabolic process |
EZH2,NCOA2,CTBP1,MITF,E2F6,KDM1A,ESRRA,KDM5B,YBX1, |
1.28E-2 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
NCOA2,CTBP1,MITF,E2F6,KDM1A,ESRRA, |
2.10E-2 |
GO:0010605
|
negative regulation of macromolecule metabolic process |
NCOA2,CTBP1,E2F6,KDM1A,BNIP3L,KDM5B, |
2.19E-2 |
GO:0034330
|
cell junction organization |
CXADR,BCL2,CDC42, |
2.55E-2 |
GO:0016481
|
negative regulation of transcription |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
2.74E-2 |
GO:0045637
|
regulation of myeloid cell differentiation |
CDK6,MITF,ESRRA, |
3.82E-2 |
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
4.06E-2 |
GO:0051172
|
negative regulation of nitrogen compound metabolic process |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
4.26E-2 |
GO:0030278
|
regulation of ossification |
CDK6,BCL2,ESRRA, |
4.72E-2 |
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter |
NCOA2,CTBP1,E2F6,KDM1A, |
4.92E-2 |
GO:0010558
|
negative regulation of macromolecule biosynthetic process |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
5.14E-2 |
GO:0031327
|
negative regulation of cellular biosynthetic process |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
5.62E-2 |
GO:0009890
|
negative regulation of biosynthetic process |
NCOA2,CTBP1,E2F6,KDM1A,KDM5B, |
6.06E-2 |
GO:0051329
|
interphase of mitotic cell cycle |
CDK6,BCL2,E2F6, |
8.11E-2 |
GO:0051325
|
interphase |
CDK6,BCL2,E2F6, |
8.57E-2 |
GO:0051726
|
regulation of cell cycle |
CDK6,BCL2,PTGS2,CDC42, |
9.01E-2 |
|
|
|
|
|
|